243 - Challenging HIV Clinical Cases

Wednesday, October 22, 2025

1:45 PM - 3:00 PM US ET

Location: Ballroom (Hall B1)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Vivek Jain, MD, MAS (he/him/his)

Professor of Medicine
Division of HIV, Infectious Diseases & Global Medicine, San Francisco General Hospital, University of California, San Francisco
San Francisco, CA, United States

Interactive Moderator(s)

Jennifer Davis, MD (she/her/hers)

Assistant Professor
College of Medicine
University of Nebraska Medical Center
Omaha, NE, United States

Slides
OB

Oliver Bacon, MD, MPH (he/him/his)

Medical Director
San Francisco City Clinic, San Francisco Department of Public Health
San Francisco, CA, United States

Panelist(s)

Lydia Barakat, MD (she/her/hers)

Associate Professor of Medicine
Internal Medicine (Infectious Diseases)
Yale School of Medicine
New Haven, CT, United States
James Brock, MD, MSCI, FACP, FIDSA (he/him/his)

Professor of Medicine
Internal Medicine, Division of Infectious Diseases
University of Mississippi Medical Center
Jackson, MS, United States
JJ

Joyce Jones, MD, MS

Assistant Professor
Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States

Disclosure(s):

Vivek Jain, MD, MAS: No financial relationships to disclose.

Jennifer M. Davis, MD: GSK/ViiV Healthcare: Grant/Research Support

Oliver Bacon, MD, MPH: No financial relationships to disclose.

Lydia A. Barakat, MD: No financial relationships to disclose.

James B. Brock, MD, MSCI, FACP, FIDSA: Gilead Sciences, Inc: Grant/Research Support

Joyce L. Jones, MD, MS: No financial relationships to disclose.

Learning Objectives:

At the conclusion of this session, participants will be able to:

recognize key indications for the use of long-acting HIV antiretroviral therapies;
identify common issues in using HIV pre-exposure prophylaxis strategies;
review management of certain HIV opportunistic infections.